Cancer-targeted and intracellular delivery of Bcl-2-converting peptide with functional macroporous silica nanoparticles for biosafe treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer-targeted and intracellular delivery of Bcl-2-converting peptide with functional macroporous silica nanoparticles for biosafe treatment

Published:2020-03 Issue: Volume:108 Page:110386
ISSN:0928-4931
Container-title:Materials Science and Engineering: C
language:en
Short-container-title:Materials Science and Engineering: C

Author:

Wu Yuehuang,Ge Pengjin,Xu Weixia,Li Mingyu,Kang Qi,Zhang Xiaokun,Xie Jingjing

Funder

National Natural Science Foundation of China

Natural Science Foundation of Fujian Province

Regional Demonstration of Marine Economy Innovative Development Project

Fujian Provincial Science and Technology Department

XMU Training Program of Innovation and Enterpreneurship for Undergraduates

Publisher

Elsevier BV

Subject

Biomaterials,Bioengineering,Mechanics of Materials

Reference36 articles.

1. MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition;He;Adv. Mater. (Deerfield Beach, Fla.),2014

2. Bcl-2-family proteins and hematologic malignancies: history and future prospects;Reed;Blood,2008

3. Novel polymeric nanoparticles for intracellular delivery of peptide Cargos: antitumor efficacy of the BCL-2 conversion peptide NuBCP-9;Kumar;Cancer Res.,2014

4. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy;Kang;Clin. Cancer Res. Off. J. Am. Assoc. Canc. Res.,2009

5. Emerging Bcl-2 inhibitors for the treatment of cancer;Azmi;Expert Opin. Emerg. Drugs,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in precision nanomedicine design targeting the anoikis-platelet interface of circulating tumor cells;Acta Pharmaceutica Sinica B;2024-08

2. Small Molecule Functional Converter of B-Cell Lymphoma-2 (Bcl-2) Suppresses Breast Cancer Lung Metastasis;ACS Pharmacology & Translational Science;2024-05-01

3. Unique Advantages of Dendrimers‐Structured Mesoporous Silica Nanoparticles over Traditional Hollow Ones in Delivering Bcl2‐Functional Converting Peptide for Multidrug Resistant Cancer Treatment;Advanced Healthcare Materials;2024-04-25

4. Identification and Characterization of a Small Molecule Bcl-2 Functional Converter;Cancer Research Communications;2024-03-04

5. Acid-Responsive Macroporous Silica Nanoparticles for Bcl-2-Functional-Converting Peptide Release and Synergism with Celastrol for Enhanced Therapy against Resistant Cancer;ACS Applied Materials & Interfaces;2023-06-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3